The independent source for health policy research, polling, and news.
1,521-1,540 of 1,685 results
President Barack Obama succeeded where many other presidents failed, but now the fate of the Affordable Care Act rests with President-elect Donald Trump.
One in four doctors practicing in the U.S. is an international medical doctor. Many foreign-born doctors practice in parts of the country where there are doctor shortages.
An aging writer discovers there are worse things than going bald after examining the side effects of a popular hair loss drug purportedly used by President Donald Trump.
Remarks by Sen. Mike Lee and Reps. Jim Jordan and Mark Meadows reflect growing uncertainty about Republicans’ path to overhaul Obamacare.
Stephanie Armour of The Wall Street Journal, Alice Ollstein of Politico and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss the suggested cuts to health programs in President Donald Trump’s budget proposal, the latest on lawsuits challenging work requirements for Medicaid enrollees and the FDA’s crackdown on e-cigarettes. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.
Amplifying the "patient voice," those with the rarest afflictions are trained to become powerful advocates for new drugs and legislation that would help the industry.
The prospect of repealing the Affordable Care Act – with no replacement ready – finds many having second thoughts.
After intense negotiations among party factions, Republican leaders unveil legislation that committees will mark up this week.
The legislation is only a first step, declaring the “intent” of the state Senate without specifics or a timetable.
Teachers and health professionals report post-election depression, anxiety and stress in young immigrants and minorities.
A drug from Marathon Pharmaceuticals has ignited a firestorm on Capitol Hill and beyond. What makes it different than the $750,000 drug that came before it?
Former FDA Commissioner Dr. Robert Califf shares his views about drug approvals, regulations and safety concerns after stepping down from the giant agency.
With high-level connections in the Capitol, Parker "Pete" Petit aims to resolve regulatory issues that have haunted his wound care company.
Trump opponents — and even some supporters — say the election and tumultuous early days of the new administration have left them anxious, angry and afraid of Facebook.
People who think the change in administrations may save them from having to pay a fine for not having insurance in 2016 could be in for a rude surprise.
Some foreign-born California residents fear they could be penalized for using Medi-Cal and other social benefits. Others, in families of mixed-immigration status, worry about jeopardizing their loved ones’ chances of becoming green-card holders or citizens.
After hearing complaints about its high price, Marathon Pharmaceuticals is pausing the launch of an $89,000 drug for a rare disease.
Giving consumers more knowledge about the costs of care has long been desired, but administration officials cautioned it could take two years or more for useful data to appear in a phone app.
The Trump administration’s first health regulation would shorten the enrollment periods and make it harder for patients to get coverage outside of that annual signup period.
As conservative physicians rise to more powerful positions in government, some question whether they speak for the nation’s doctors.
© 2026 KFF